Updated: Apr 19
The past two years have presented an enormous shift in the life science, biopharmaceutical, and med-tech industry. The speed and adaptation of companies to develop COVID-19 tests, therapeutics, and vaccines (and the facilities needed to support these products) has highlighted the need for a refocused effort.
Speed to market for these products has never been more critical, and this is a trend that will continue long after the COVID-19 crisis has been eased. Furthermore, data-driven analytics within the pharmaceutical world have allowed researchers and healthcare providers to potentially gather, diagnose and treat from aggregated electronic medical records (EMR) to further speed-up reaction time for treatment. This speed to market focus results in incredibly challenging, yet rewarding, projects.
This guide helps focus on the tools needed to achieve enhanced speed to market construction projects, in addition to the ongoing reaction and focus of electronic medical records (EMR’s) for future research, diagnoses, and treatment.